IFO - Istituto Regina Elena; Oncologia Medica

Rome, Lazio 00144

0 studies enrolling now · 1 studies all time

What they study most

Advanced BRAFV600 Wild-type Melanoma

Studies at this site

• A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma — Stopped early